REGENXBIO INC (RGNX) Stock Earnings & Estimates
NASDAQ:RGNX - US75901B1070 - Common Stock
8.97 USD
-0.04 (-0.44%)
9 USD
+0.03 (+0.33%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 112.7M -76.04% | 90.242M -19.93% | 83.328M -7.66% | 300.19M 260.25% | 238.79M -20.45% | 329.49M 37.98% | 463.95M 40.81% | 642.31M 38.44% | 841.72M 31.05% | 1.008B 19.75% | 1.042B 3.37% | |
| EBITDA YoY % growth | -250M -247.41% | -250.808M -0.32% | -214.13M 14.62% | 50.608M 123.63% | -38.681M -176.43% | -63.673M -64.61% | -62.059M 2.53% | 75.731M 222.03% | 178.43M 135.61% | 188.94M 5.89% | 217.25M 14.98% | |
| EBIT YoY % growth | -262.9M -264.31% | -268.128M -1.99% | -230.345M 14.09% | 27.506M 111.94% | -144.063M -623.75% | -101.415M 29.60% | -95.718M 5.62% | 55.302M 157.78% | 238.69M 331.61% | 291.93M 22.31% | 317.95M 8.91% | |
| Operating Margin | -233.27% | -297.12% | -276.43% | 9.16% | -60.33% | -30.78% | -20.63% | 8.61% | 28.36% | 28.96% | 30.51% | |
| EPS YoY % growth | -6.50 -337.23% | -6.03 7.23% | -4.56 24.38% | -1.71 62.53% | -2.69 -57.59% | -2.13 20.74% | -2.49 -16.61% | -0.65 73.98% | 2.31 455.91% | 8.34 261.95% | 8.34 |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 48.80% | 0.09 108.79% | -0.89 -837.80% | -1.22 11.90% | -1.17 -95.40% | -0.20 -320.69% | -1.07 -20.97% | -0.83 32.05% | -0.75 35.51% | -0.32 -61.46% |
| Revenue Q2Q % growth | 70.653M 191.99% | 87.707M 313.44% | 49.478M -44.41% | 34.299M 60.58% | 42.197M -40.28% | 94.217M 7.42% | 36.404M -26.42% | 45.584M 32.90% | 59.864M 41.87% | 81.019M -14.01% |
| EBITDA Q2Q % growth | -72.005M -44.34% | 57.181M 262.66% | 41.473M 157.88% | -55.131M 0.52% | -61.628M 14.41% | -54.57M -195.43% | -50.918M -222.77% | -38.801M 29.62% | -34.945M 43.30% | -12.128M 77.78% |
| EBIT Q2Q % growth | 4.288M 106.91% | -2.287M 95.55% | -38.192M -414.94% | -61.316M 3.10% | -72.549M -1,791.91% | -2.9M -26.81% | -54.958M -43.90% | -42.779M 30.23% | -38.984M 46.26% | -16.238M -459.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.38 -31.43% | -1.12 | -0.26 | -22.99% |
| Q1 2025 Q2Q % growth | 0.12 109.02% | 0.49 | -0.37 | -75.63% |
| Q4 2024 Q2Q % growth | -1.01 29.37% | -1.17 | 0.16 | 13.65% |
| Q3 2024 Q2Q % growth | -1.17 17.02% | -1.14 | -0.03 | -2.21% |
| Q2 2024 Q2Q % growth | -1.05 36.75% | -1.32 | 0.27 | 20.28% |
| Q1 2024 Q2Q % growth | -1.33 13.07% | -1.28 | -0.05 | -3.57% |
| Q4 2023 Q2Q % growth | -1.43 -3.62% | -1.30 | -0.13 | -10.34% |
| Q3 2023 Q2Q % growth | -1.41 19.43% | -1.55 | 0.14 | 8.92% |
| Q2 2023 Q2Q % growth | -1.66 -5.06% | -1.41 | -0.25 | -17.51% |
| Q1 2023 Q2Q % growth | -1.53 14.53% | -1.57 | 0.04 | 2.39% |
| Q4 2022 Q2Q % growth | -1.38 -120.69% | -1.26 | -0.12 | -9.61% |
| Q3 2022 Q2Q % growth | -1.75 -27.74% | -1.49 | -0.26 | -17.40% |
| Q2 2022 Q2Q % growth | -1.58 -16.18% | -1.56 | -0.02 | -1.43% |
| Q1 2022 Q2Q % growth | -1.79 -49.17% | -1.34 | -0.45 | -33.35% |
| Q4 2021 Q2Q % growth | 6.67 637.90% | 4.81 | 1.86 | 38.79% |
| Q3 2021 Q2Q % growth | -1.37 -418.60% | -1.10 | -0.27 | -24.56% |
| Q2 2021 Q2Q % growth | -1.36 -49.45% | -1.14 | -0.22 | -19.51% |
| Q1 2021 Q2Q % growth | -1.20 -11.11% | -1.31 | 0.11 | 8.29% |
| Q4 2020 Q2Q % growth | -1.24 -72.22% | -0.44 | -0.80 | -179.92% |
| Q3 2020 Q2Q % growth | 0.43 145.74% | -1.03 | 1.46 | 141.67% |
| Q2 2020 Q2Q % growth | -0.91 -2,175.00% | -0.90 | -0.01 | -0.69% |
| Q1 2020 Q2Q % growth | -1.08 -21.35% | -0.89 | -0.19 | -21.70% |
| Q4 2019 Q2Q % growth | -0.72 | -0.45 | -0.27 | -60.43% |
| Q3 2019 Q2Q % growth | -0.94 | -0.73 | -0.21 | -29.07% |
| Q2 2019 Q2Q % growth | -0.04 | -0.62 | 0.58 | 93.59% |
| Q1 2019 Q2Q % growth | -0.89 | -0.88 | -0.01 | -1.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 21.359M -4.20% | 28.675M | -7.316M | -25.51% |
| Q1 2025 Q2Q % growth | 89.012M 469.79% | 104.01M | -14.998M | -14.42% |
| Q4 2024 Q2Q % growth | 21.214M -4.50% | 24.229M | -3.015M | -12.44% |
| Q3 2024 Q2Q % growth | 24.197M -16.31% | 24.06M | 137K | 0.57% |
| Q2 2024 Q2Q % growth | 22.295M 11.60% | 23.432M | -1.137M | -4.85% |
| Q1 2024 Q2Q % growth | 15.622M -18.37% | 23.995M | -8.373M | -34.89% |
| Q4 2023 Q2Q % growth | 22.213M -29.03% | 34.679M | -12.466M | -35.95% |
| Q3 2023 Q2Q % growth | 28.914M 9.11% | 26.687M | 2.227M | 8.34% |
| Q2 2023 Q2Q % growth | 19.977M -38.72% | 35.195M | -15.218M | -43.24% |
| Q1 2023 Q2Q % growth | 19.138M -13.79% | 31.208M | -12.07M | -38.68% |
| Q4 2022 Q2Q % growth | 31.3M -92.15% | 38.2M | -6.9M | -18.06% |
| Q3 2022 Q2Q % growth | 26.5M -13.96% | 31.428M | -4.928M | -15.68% |
| Q2 2022 Q2Q % growth | 32.6M 48.18% | 27.322M | 5.278M | 19.32% |
| Q1 2022 Q2Q % growth | 22.2M 17.46% | 29.792M | -7.592M | -25.48% |
| Q4 2021 Q2Q % growth | 398.7M 1,763.08% | 277.17M | 121.53M | 43.85% |
| Q3 2021 Q2Q % growth | 30.8M -68.86% | 42.294M | -11.494M | -27.18% |
| Q2 2021 Q2Q % growth | 22M 32.53% | 29.603M | -7.603M | -25.68% |
| Q1 2021 Q2Q % growth | 18.9M 7.39% | 23.697M | -4.797M | -20.24% |
| Q4 2020 Q2Q % growth | 21.4M 81.36% | 62.733M | -41.333M | -65.89% |
| Q3 2020 Q2Q % growth | 98.9M 572.79% | 21.793M | 77.107M | 353.82% |
| Q2 2020 Q2Q % growth | 16.6M 110.13% | 22.511M | -5.911M | -26.26% |
| Q1 2020 Q2Q % growth | 17.6M 1,855.56% | 18.819M | -1.219M | -6.48% |
| Q4 2019 Q2Q % growth | 11.8M | 40.463M | -28.663M | -70.84% |
| Q3 2019 Q2Q % growth | 14.7M | 10.747M | 3.953M | 36.78% |
| Q2 2019 Q2Q % growth | 7.9M | 17.316M | -9.416M | -54.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -248.17% | 30.91% | -2915.08% | -200.93% |
| Revenue | -37.04% | 49.15% | -15.65% | -12.88% |